QUBIS, the commercialization arm of Queen’s University Belfast, focuses on transforming academic research into commercial innovation. Founded in 1984, QUBIS has a long track record of creating new technology startups by helping commercialize leading-edge technology from Queen's research base. They work with academics, entrepreneurs, and investors to create spin-off companies that combine cutting-edge R&D with market-focused products and services, resulting in a positive impact on local and global markets. QUBIS provides support to academic researchers from IP discovery and protection through IPO to business growth strategies, aiming to ensure the sustainable success of their spin-outs. They network and partner with experienced entrepreneurs and investors, to bring expertise and resources to drive growth. They seek to maximize the positive change that Queen's research brings to the Northern Irish and wider economies, attracting entrepreneurial talent and fostering visionary research. They aim to ensure Queen's University research and innovation is a force for positive change in the Northern Irish and wider economies and societies. Their approach includes identifying and protecting intellectual property, helping academics access funding for translational research, connecting them with industry partners, and providing support for launching and scaling their businesses. Their goal is to take world-class innovation from Queen’s University Belfast and have a real-world impact on local and global markets, economies, and lives. As the commercialization arm of a prominent university, QUBIS leverages access to research and talent to fuel the creation and growth of new technology companies. They are committed to fostering innovation and maximizing the economic and social impact of Queen’s University’s research.
Bevorzugte Reifephase für die erste Finanzierung.
Digital Technology, Software, IT, Digital Pathology, Pharma, Antibody Engineering, Medical Training Manikins, Digital Signal Processing, Raman Spectroscopy, Engineering, Environmental, Life Science, Scientific
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
